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Background: Adipose hypertrophy limits fat cell oxygenation, promotes scarring, and associates with increased local
glucocorticoid regeneration (higher 11HSD1 enzyme).
Results: 11HSD1 knock-out mice have reduced scarring and better vascularization and oxygenation in their adipose tissue.
Conclusion: Elevated adipose 11HSD1 contributes to obesity pathogenesis by suppressing adipose angiogenesis.
Significance:Enhancement of adipose oxygenation and vascularization is a novel therapeuticmodality for 11HSD1 inhibitors.
In obesity, rapidly expanding adipose tissue becomes hypoxic,
precipitating inflammation, fibrosis, and insulin resistance.
Compensatory angiogenesis may prevent these events. Mice
lacking the intracellular glucocorticoid-amplifying enzyme
11-hydroxysteroid dehydrogenase type 1 (11HSD1/) have
“healthier” adipose tissue distribution and resist metabolic dis-
ease with diet-induced obesity. Here we show that adipose tis-
sues of 11HSD1/ mice exhibit attenuated hypoxia, induc-
tion of hypoxia-inducible factor (HIF-1) activation of theTGF-
/Smad3/-smooth muscle actin (-SMA) signaling pathway,
and fibrogenesis despite similar fat accretion with diet-induced
obesity. Moreover, augmented 11HSD1/ adipose tissue
angiogenesis is associated with enhanced peroxisome prolifera-
tor-activated receptor  (PPAR)-inducible expression of the
potent angiogenic factors VEGF-A, apelin, and angiopoietin-
like protein 4. Improved adipose angiogenesis and reduced
fibrosis provide a novel mechanism whereby suppression of
intracellular glucocorticoid regeneration promotes safer fat
expansion with weight gain.
In obesity, adipose tissue expansion may exceed compensa-
tory vascular supply. Consequently, adipose tissue hypoxia is
postulated to precipitate inflammatorymacrophage infiltration
and impair insulin signaling (1–4). Induction of hypoxia-in-
ducible factors (HIFs)3 is a molecular hallmark of tissue
hypoxia. Both HIF-1 and HIF-2 are involved in adipocyte
differentiation and responses to hypoxia in vitro (5, 6). HIF-1
associates with hypoxic and inflammatory changes in adipose
tissues in vivo, and transgenic overexpression of HIF-1 in adi-
pose tissue causes fibrosis (7).
Altered glucocorticoid action has a major impact upon adi-
pose tissue distribution and insulin sensitivity. Elevated adipose
tissue levels of the intracellular glucocorticoid-regenerating
enzyme 11-hydroxysteroid dehydrogenase type 1 (11HSD1)
are found in human obesity (8, 9). Modeling this by adipose-
specific overexpression in mice drives visceral obesity and a
metabolic syndrome (10). In contrast, 11HSD1 gene knock-
out (11HSD1/) mice are protected from high fat diet-in-
duced metabolic disease (11, 12) and adipose inflammation
(13). In addition, 11HSD1 deficiency is associated with
enhanced angiogenesis during wound healing and in the myo-
cardium following ischemia (14, 15). We hypothesized that the
metabolically “healthy” adipose tissue found with 11HSD1
deficiency might have its origin in improved adipose tissue
angiogenesis, with consequent improvement in hypoxia-in-
duced fibrosis.We therefore examined the impact of 11HSD1
deficiency on adipocyte paracrine, stromal proangiogenic
responses, and the consequent effects on adipose tissue vascu-
larization and fibrosis in dietary obesity.
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EXPERIMENTAL PROCEDURES
Diet-induced Obesity (DIO)—Adult male 11HSD1/ and
congenic C57Bl/6J controls (12, 13) were single-housed (12-h
light/12-h dark cycle) and given food and water ad libitum.
Mice (n 6–8 per group) were randomized to standard chow
or a high fat (HF) diet, 58% calories as fat (Research Diets
D12331), for 12 weeks.
Pimonidazole Staining—To assess adipose tissue hypoxia in
vivo, mice were injected intraperitoneally with 60 mg/kg of
pimonidazole (HypoxyprobeTM-1 Plus kit, Chemicon Interna-
tional), 30 min prior to sacrifice. Subcutaneous (scAT) and
mesenteric (mesAT) adipose tissues were collected in formalin
and paraffin-embedded. 4-m sections were incubated with
mAb1 conjugated with FITC at a 1:100 dilution for 30 min at
room temperature. A secondary anti-FITCmAbwas applied at
a 1:100 dilution for 30 min (according to the manufacturer’s
instructions). Pimonidazole adduct staining was visualized
using the diaminobenzidine chromogen-A system (DAKO).
Sections were rinsed and counterstained with hematoxylin and
imaged using a Zeiss microscope. 30–40 high power fields
FIGURE 1. Less adipose hypoxia in 11HSD1/ mice. A and B, representative images of Hypoxyprobe staining of subcutaneous (A) and mesenteric (B)
adipose tissue in chow-fed control (WT CD; quantification histogram: hatched bars), HF-fed control (WT HF; quantification histogram: white bars), and HF
11HSD1/ (KO HF; quantification histogram: black bars) mice (n  6). 30–40 high power fields (magnification 200) per section were quantified. Brown
adducts indicate areas of low oxygen availability. Note the unstained blood vessel that acts as an internal negative control. n 6/group, *, p 0.05, **, p
0.01,***, p 0.001 by ANOVA. HFD, high fat diet.
TABLE 1
Similar body weight and adipose mass gain in 11HSD1/mice after HF feeding
11HSD1/ and control (C57BL/6) mice gained similar weight (n 6). Body fat distribution and subcutaneous andmesenteric fat deposition were similar after 12 weeks
on HF diet. * indicates significant differences between control chow and high fat diet in both genotypes. CD, chow-fed; HFD, high fat diet-fed; BW, body weight.
C57BL/6 CD C57BL/6 HFD 11HSD1/HFD p values
Terminal BW (g) 38.8 3.2* 49.2 1.7 53 1.1 0.0001
BW gain (g) 5.9 0.3* 16.1 1.2 17.1 1.2 0.0001
scAT (g) 0.4 0.03* 1.0 0.06 1.2 0.09 0.0001
mesAT (g) 0.7 0.06* 1.5 0.1 1.6 0.1 0.0001
scAT/BW ratio 0.010 0.0006* 0.020 0.001 0.022 0.001 0.0001
mesAT/BW ratio 0.018 0.0009* 0.030 0.001 0.031 0.001 0.0006
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(magnification 200) per section were randomly selected for
each slide by an assessor blind to genotype. Diaminobenzidine
brown staining was quantified using Photoshop PS3 and nor-
malized to the total number of pixels.
RNA Extraction and Quantitative Real Time PCR—scAT
and mesAT were weighed and snap-frozen in liquid nitrogen,
and RNA was extracted as described (12). 1 g of RNA was
reverse-transcribed using the SuperScript III cDNA synthesis
kit (Invitrogen) according to the manufacturer’s instructions.
Real time PCR was performed with the LightCycler (Roche
Applied Science), using TaqMan assays for all genes measured
and correcting for 18 S and -actin expression.
Immunoblotting—Frozen adipose tissues were homogenized
in a urea/SDS buffer supplemented with Complete protease
inhibitor (Roche Applied Science). The fat layer was removed
by centrifugation (4000 rpm, 10 min). The protein concentra-
tion was determined using a Bio-Rad assay kit. Proteins were
separated on 7–12% Bis-Tris gels and transferred to PVDF
membranes (Millipore). The antibodies used were rabbit anti-
mouse HIF-1, HIF-2, PHD2, PHD1, PHD3 (Novus Biologi-
cals), anti-phospho-Smad3 (Cell Signaling), anti-Smad2/3 (Cell
Signaling), anti--SMA (Sigma), and HRP-conjugated anti--
actin (Abcam). The primary antibodies were detected with sec-
ondary HRP-IgGs (Dako) using ECL detection (GE Health-
care). Densitometry was performed using ImageJ, and protein
levels were corrected for -actin.
Immunohistochemistry—For the detection of collagen depo-
sition, formalin-fixed, paraffin-embedded sections (4m)were
stained with picrosirius red (Sigma). Myofibroblasts were
detected with a mouse monoclonal antibody to -SMA
(Sigma). An anti-CD31 antibody (Abcam) was used for identi-
fying endothelial cells/vessels. Secondary antibodies were all
from Dako. Binding of primary antibody was visualized using
diaminobenzidine chromogen-A (Dako) after counterstaining
with hematoxylin.
SVF Cell Preparation and in Vitro Hypoxia—Adipose tissue
was removed fromHF-fed mice into warmed Krebs’ buffer and
collagenase type 1 (Worthington Biochemicals)-digested as
described (30). Briefly, after 1 h of digestion and centrifugation
to separate from adipocytes, stromovascular fraction (SVF)
cells were seeded at 2.5  105 cells/well in DMEM. On day 2,
culture medium was replaced with 1% O2 preconditioned
medium. Cells were left at 1%O2 in a hypoxic chamber (1%O2)
for 6 h and then lysed in TRIzol, and RNA was extracted as
above.
Rosiglitazone Treatment of Primary Adipocytes—The ceil-
ing-cultured adipocytes from collagenase digestion (see above)
were filtered through a 200-m size exclusion mesh and then
centrifuged. Equal volumes of fractionated adipocyteswere cul-
tured in DMEM medium (Lonza, Berkshire, UK) for 16 h at
37 °C, 5% CO2 in the presence or absence of 1M rosiglitazone.
Adipocytes were lysed in TRIzol, and total RNA was extracted
as above.
Angiogenesis Bioassays—Strips of periaortic adipose tissue
(immediately adjacent to the adventitia) were isolated from the
thoracic aortas of C57Bl/6 or 11HSD1/mice and incubated
FIGURE 2. Reduced adipose HIF-1 in 11HSD1/mice. A and B, representative immunoblots of HIF-1 and HIF-2 protein levels (A) and PHD 1–3 protein
levels (B) in scAT. Right panels, quantification histograms showing the relative protein levels corrected for-actin controlmice on chowdiet (hatched bars, n
6), control HF (white bars,n 6), and 11HSD1/HFmice (black bars,n 6). *,p 0.05, ***,p 0.001byANOVA.AU, arbitrary units;WTCD, chow-fed control;
wt HFD, HF-fed control; KO HFD, HF 11HSD1/.
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(20 mg of periaortic adipose/ml; 24 h at 37 °C) in DMEM con-
taining 4.5 g/liter glucose, 584mg/liter L-glutamine, 75mg/liter
L-ascorbic acid, 10 mg/liter heparin, 100 units/ml penicillin,
100 g/ml streptomycin, 250 ng/ml amphotericin B, and 0.2%
BSA. Adipose tissue was removed from the conditioned
medium, which was aliquoted and stored at 80 °C. Control
medium (vehicle) was obtained following the same procedure
without adipose tissue. Tube formation from mouse aortic
rings was performed as described (14). Briefly, aortic rings (1
mm in length) from C57Bl/6 mice were embedded in Matrigel
and incubated (DMEM, 37 °C; 5% CO2) in 50% DMEM; 50%
periaortic fat conditionedmedium or 50%DMEM; 50% control
medium for 7 days, with medium refreshed every 48 h. Aortic
rings cultured under these conditions in Matrigel spontane-
ously generated endothelial tube-like structures. The impact of
periaortic fat conditioned medium on angiogenesis was quan-
tified by counting the number of tube-like structures every
other day (by an operator blinded to treatment).
Statistical Analysis—Values are means  S.E. Simple com-
parisonswere analyzed using Student’s t test. Formultiple com-
parisons, differences between genotypes and the effect of treat-
ment(s) were analyzed by two-way ANOVA with subsequent
Tukey’s post hoc test. Significance was set at p 0.05.
RESULTS
11HSD1/ Adipose Tissue Is Resistant to Hypoxia with
Obesity—Weight gain and fat mass were similar after 12 weeks
of HF feeding in both genotypes (Table 1). This intermediate
time point suggests that a convergent phase in fat accumulation
follows an earlier generalized reduction in fat mass (13) and
precedes a later beneficial redistribution of fat away from vis-
ceral depots and into peripheral fat depots (12).
Despite similar scAT depot expansion in 12-week HF-fed
11HSD1/ mice, there was markedly less adipose tissue
pimonidazole staining and hence hypoxia than in HF-fed con-
trol (WT) mice (Fig. 1). Importantly, mesAT from chow-fed
animals exhibited 14-fold (p  0.005) greater pimonidazole
staining than scAT, suggesting that marked hypoxia occurs
under basal circumstances in this depot. HF feeding signifi-
cantly induced adipose HIF-1 in control mice, whereas
HIF-1 remained very low in similarly obese HF-fed
11HSD1/mice (Fig. 2A and supplemental Fig. S1). HIF-2
protein was unaffected by HF or 11HSD1 genotype (Fig. 2A),
suggesting that it does not play a role in adipose hypoxic
responses in vivo.
HIF prolyl hydroxylases (PHD 1–3 (also known as EGLNs))
degrade HIFs under normoxic conditions by hydroxylation of
the two proline residues in the oxygen-dependent degradation
domain of HIF- (16–18). The role of PHDs in adipose tissue
and obesity is currently unknown. Adipose tissue PHDmRNAs
were unaffected by HF feeding or genotype (supplemental Fig.
S2). However, PHD1 and PHD2 protein levels were suppressed
by HF feeding (Fig. 2B). Thus, although lower PHD1 and PHD2
(and hence reduced HIF-1 degradation) may contribute to
HIF-1 elevation with DIO in controls, variation in PHDs does
not explain the lower levels of HIF-1 in adipose tissue with
11HSD1 deletion.
To determine whether 11HSD1/ mice have altered
responses to hypoxia in the fibrogenic adipose SVF, HIFs and
FIGURE 3. 11HSD1/ show similar HIF response after acute hypoxia in vitro. A–E, SVF from HF control at 21% oxygen (white) and 1% oxygen (diagonal
hatched) andHF11HSD1/ at 21%oxygen (black) and 1%oxygen (vertical hatched). Cellswere kept in 1%oxygen for 6 h. Data are presented asmeans S.E.
of SVF from four individualmice.mRNA levels ofHIF-1 (A), HIF-2 (B), PHD1 (C), PHD2 (D), andPHD3 (E)weredetermined. *,p0.05, ***,p0.001, by two-way
ANOVA. AU, arbitrary units.
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PHDs were measured in SVF cells from HF-fed mice under
normoxia (21% O2) or acute hypoxia (1% O2) in vitro. In both
genotypes, HIF-1, but not HIF-2, mRNA levels were mark-
edly and similarly up-regulated by hypoxia (Fig. 3,A and B). All
three PHDs were expressed in SVF cells and were similarly up-
regulated by hypoxia (Fig. 3, C–E). Thus, the attenuation of
HIF-1 responses to HF in 11HSD1/ adipose tissue in vivo
is likely due to the reduced tissue hypoxia rather than an intrin-
sic difference in hypoxia responses.
HF-fed 11HSD1/ Mice Have Reduced Adipose Collagen
Deposition and Expression of Fibrogenic Mediators—To deter-
minewhether obesity-inducedhypoxia impacted adipose fibro-
sis, as in liver (19), we analyzed collagen deposition. Staining for
picrosirius red-reactive collagens I and III was low and compa-
rable between genotypes in chow-fed scATandmesAT.HFdiet
markedly induced collagen staining in adipose tissue, observed
as broad strands transversing the tissue and around individual
adipocytes (Fig. 4A). 11HSD1/mice exhibited significantly
less collagen deposition in response to HF in both fat depots
with much thinner fibrillar streaks and little staining around
adipocytes (Fig. 4A).
Tissue fibrosis is characterized by increased transdifferentia-
tion of fibroblasts to activatedmyofibroblasts and collagen dep-
osition (20). 11HSD1/ adipose tissue exhibited reduced
-SMA staining in both scAT and mesAT adipose in response
to HF (Fig. 4B). Consistent with reduced fibrosis and fewer
-SMA-positive cells, glucocorticoid-regulated Col11mRNA
levels were lower in 11HSD1/ adipose tissue (Fig. 5C).
Other genes involved in fibrosis were unaltered in HF-fed
11HSD1/ adipose tissues, including Col31 and Col61
(Fig. 5C). Activation of the TGF-/Smad signaling pathway is
critical in driving fibrogenesis in liver (21) and in adipose tissue
(7). To investigate the impact of intra-adipose glucocorticoid
deficiency on adipose fibrosis, we measured TGF-/Smad sig-
naling. TGF- mRNA (Fig. 5C) and total Smad2/3 (Fig. 5A)
levels were comparable across genotypes and diet. HF feeding
significantly induced Smad3 phosphorylation in control mice
(3-fold, p  0.01, Fig. 5A and supplemental Fig. S3). However,
Smad3 phosphorylation levels were lower in HF-fed
11HSD1/ (Fig. 5A). In vitro hypoxia rapidly up-regulated
TGF- in SVF cells from control mice, whereas TGF- was
unchanged in 11HSD1/ SVF cells (supplemental Fig. S4).
Moreover, the fibrosis-associated 63-kDaMMP14 pro-enzyme
was elevated by HF diet in adipose tissue of control but not
11HSD1/ mice (Fig. 5B). Other matrix remodeling
enzymes were unaltered including TIMP-1, MMP2, and
MMP13 mRNA levels (Fig. 5C).
Increased Angiogenesis in 11HSD1/Adipose Tissue—We
next explored whether the attenuation of adipose tissue
hypoxia and fibrosis responses inHF-fed 11HSD1/ adipose
FIGURE 4. Attenuated adipose tissue fibrosis in HF 11HSD1/. A, representative images of picrosirius red (S RED) staining in subcutaneous (sc) and
mesenteric (mes) adipose. Bold arrowheads show collagen deposition surrounding the adipocytes, and arrows point to the streaks of collagen between
adipocytes. WT CD, chow-fed control; wt HF, HF-fed control; KO CD, chow-fed 11HSD1/; KO HF, HF 11HSD1/. B, -SMA immunohistochemistry in
mesenteric adipose; brown stainedmyofibroblasts are indicated by arrows. 30–40 fields (magnification200) per sectionwere assessed in each group. Right,
quantification histograms (n 6/genotype) showing WT HF (white bars) versus KO HF (black bars) *, p 0.05.
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tissues was associated with enhanced angiogenesis. The vessel-
to-adipocyte ratio (correcting for adipose hypertrophy) was
higher in HF-fed 11HSD1/mice than in control mice (Fig.
6A) despite comparable reductions in total vessel (Fig. 6B) and
fat cell numbers (Fig. 6C). This appeared to be a direct effect of
11HSD1/ adipose tissue on functional induction of angio-
genesis because exposure of control aortic rings to
11HSD1/ adipose tissue-conditioned medium induced
greater angiogenesis (3-fold, p  0.01) than control (1.5-fold,
p 0.05) adipose tissue medium (Fig. 7).
To explore the potential adipose tissue factors involved, we
measured key angiogenic gene expression levels. VEGF-A,
ANGPTL4, and apelin mRNA were more highly expressed in
adipose tissue of 11HSD1/ than in control mice (Fig. 8A).
SVF endothelial cells are key to adipose tissue expansion (22).
Consistent with the in vivo findings, normoxic SVF cells from
11HSD1/ adipose tissue had higher VEGF-A and ANG-
PTL4 expression (Fig. 8, B and C). Hypoxia induced SVF cell
VEGF-A and ANGPTL4 mRNA expression to a greater extent
in 11HSD1/ (Fig. 8B).
To determine whether the increased PPAR sensitivity of
11HSD1/ adipocytes (13) might contribute in a paracrine
manner to enhanced SVF angiogenic responses, primary
mesAT adipocytes from HF-fed mice were treated with the
PPAR agonist rosiglitazone (1 M) for 24 h. As in vivo, ANG-
PTL4 (although not VEGF) was more highly expressed in
11HSD1/ adipocytes in vitro (Fig. 9B). Rosiglitazone up-
regulated adipose ANGPTL4 with a 2-fold greater effect in
FIGURE 5. Reduced profibrotic signaling in 11HSD1/. A and B, representative adipose Western blots of phosphorylated Smad3 (Smad3P) (A) and
unphosphorylated Smad2/3 protein pro-enzyme and activeMMP14 (B). Lower panels, protein quantification histograms for controlmice on chowdiet (WTCD,
hatched bars, n 4), control HF (WT HFD, white bars, n 4), and 11HSD1/ HF mice (KO HFD, black bars, n 4). AU, arbitrary units. C, mRNA of a panel of
profibrotic genes (n8/genotype).White andblackbars, differencesbetweencontrol onHF (white bars) and11HSD1/onHF (blackbars) by Student’s t test.
*, p 0.05, **, p 0.01.
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11HSD1/ adipocytes. VEGF-A was induced by rosiglita-
zone in 11HSD1/ but not control adipocytes (Fig. 9A).
DISCUSSION
Here we show that relative glucocorticoid deficiency within
adipose tissue is permissive for angiogenesis in response to
DIO, thus preventing severe hypoxia and consequent inflam-
mation, metabolic dysfunction, and fibrosis. We find that DIO
induces more severe hypoxia in mesenteric AT than in subcu-
taneous AT. This is associated with HIF-1 induction through
reduced PHD1- and PHD2-mediated HIF degradation. This
cascade of responses associates with induction of TGF-/
Smad/-SMA signaling, myofibroblast activation, increased
collagen deposition, and MMP14 induction in HF-fed
C57BL/6J but not 11HSD1/mice. Increased PPAR activa-
tion and induction of adipocyte angiogenic factors associates
with the improved 11HSD1/ adipose tissue phenotype.
This work suggests that a cascade of failed angiogenesis leads to
tissue hypoxia and fibrosis in rapidly expanding adipose tissue
in obesity. This is ameliorated with intra-adipose glucocorti-
coid deficiency.
Adipose tissue hypoxia mediates insulin resistance and
inflammation in obesity (1–4). Moreover, hypoxia is profi-
brotic in adipose tissue, with transgenic overexpression of adi-
pose-HIF-1 leading to exacerbated collagen deposition and
fibrosis (7). Although persistent inflammation precedes fibrosis
(23), it is unclear whether chronic low grade inflammation of
obesity alters angiogenesis-dependent hypoxia and consequent
adipose tissue fibrosis. Loss of the potent angiogenic factor
VEGF in myeloid cells leads to excessive collagen deposition
FIGURE 6. Higher vessel-to-adipocyte ratio in 11HSD1/ in obesity. Top panels, representative pictures (200 magnification) showing vessel staining
using a CD31 antibody. Arrows indicate individual CD31-positive cells, and bold arrowheads indicate stained vessels. 30–40 fields per section were randomly
selected, and the number of vessels positively staining for CD31normalized to the total number of adipocyteswas quantified blind to genotype.CD, chow-fed.
A–C, quantification of total vessels to adipocyte ratio (A), total vessel number per area (mm2) (B), and total adipocyte number per area (mm2) (C). n 4, *, p
0.05, **, p 0.01.
FIGURE 7. Higher capacity of adipose-mediated tube-like structure for-
mation in 11HSD1/ mice. The number of tube-like structures formed
frommouse aortic rings after the addition of vehicle (VEH, hatched bars), wild
type periaortic fat conditionedmedia (WT PACM,white bars), or 11HSD1/
periaortic fat conditionedmedia (KO PACM, black bars) was assessed. n 4, *,
p 0.05, **, p 0.01.
Reduced Adipose Fibrosis in 11HSD1Deficiency
4194 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 6•FEBRUARY 3, 2012
 by guest on June 19, 2013http://www.jbc.org/Downloaded from 
and fibrosis, indicating that inflammatory cell-derived VEGF is
required for vascular remodeling (24). Failure of extracellular
matrix remodeling and/or neovascularization during adipose
expansion could feasibly lead to adipose tissue fibrosis. Indeed,
genetically obese mice and obese humans show significantly
reduced adipose VEGF-A accompanied by lower capillary den-
sity (4, 25), suggesting reduced adaptive angiogenesis. Although
hypoxia up-regulates VEGF-A, the protective angiogenic
response observed in 11HSD1/ mice did not follow the
canonical hypoxia-HIF-dependent pathway. HIF-independent
regulation ofVEGF-Aand angiogenesis throughPPAR coacti-
vator PGC-1-mediated responses occurs in skeletal muscle
(26) and brain (27). Moreover, induction of HIF-1 in DIO or
adipose HIF-1 overexpression does not increase VEGF-A (7).
Glucocorticoids potently suppress angiogenesis through inhi-
bition of VEGF-A (28, 29). Consistent with this, reduced
hypoxia and fibrosis in adipose tissue from 11HSD1/mice
showed augmented PPAR activation that is associated with
induction of adipocyte VEGF-A and ANGPLT4 and sustained
vessel density. Moreover, the SVF cells (fibroblast/endothelial
population) are more responsive to DIO-mediated hypoxia in
11HSD1/ mice, driving beneficial adipose tissue remodel-
ing. 11HSD1 is highly expressed in the fibroblastic preadi-
pocytes (30) and not the SVFmacrophages (13), suggesting that
FIGURE 8.Higher expression of proangiogenic genes in 11HSD1/ in obesity.A, adiposemRNA levels of a panel of potent angiogenic factors, corrected
for -actin (n 8). The bars indicate the following: SVF from HF control at 21% oxygen (white bars), 1% oxygen (diagonal hatched bars), HF 11HSD1/ 21%
oxygen (black bars) and 1%oxygen (vertical hatched bars). Cellswere kept in 1%oxygen for 6 h. Data are presented asmeans S.E. SVFwas prepared from four
individual mice. AU, arbitrary units. B and C, mRNA levels of VEGF-A (B) and ANGPTL4 (C). *, p 0.05, **, p 0.01, and ***, p 0.001.
FIGURE 9.11HSD1/ adipocytes aremore sensitive toPPAR-mediated angiogenic gene induction.A and B, VEGF-A (A) andANGPTL4 (B)mRNA levels
in adipocytes fromHF-fed control mice (white bars, n 4), rosiglitazone-treatedmice (diagonal hatched bars, n 6), 11HSD1/-untreatedmice (black bars,
n 4) and rosiglitazone-treated mice (vertical hatched bars, n 6). Two-way ANOVA, *, p 0.05, **, p 0.01. AU, arbitrary units.
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11HSD1/ preadipocytes and/or endothelial cells likely
mediate the beneficial response to hypoxia/inflammation and
fibrosis associated with obesity.
Distinct adipose depots exhibited different degrees of
hypoxia, under basal or obesogenic conditions. Thus, mesAT is
more hypoxic as compared with scAT depot. This suggests that
hypoxia does not progress uniformly between depots, most
probably due to differences in the initial degree of depot vascu-
larization or in the rate/capacity of neovascularization during
expansion. This is consistent with greater capillary density and
angiogenic capacity in human subcutaneous versus visceral adi-
pose tissue (25, 31). This suggests that individuals prone to vis-
ceral fat accumulation are at higher risk of hypoxia-induced
metabolic dysfunction. Our finding that glucocorticoid defi-
ciency is associated with fewer hypoxic areas, and consequently
normoxic HIF-1 levels, in both depots, in contrast to what is
seen in DIO or genetically obese mice (1, 32), suggests a meta-
bolic/vascular advantage during adipose expansion. Glucocor-
ticoids could exacerbate the induction of HIF-1-dependent
gene expression under hypoxic conditions and enhance the
hypoxicmetabolic insult (29, 33). Importantly, our data suggest
that HIF-1 might be regulated (stabilized/activated) by other
pathway(s) apart from tissue hypoxia per se during obesity such
as inflammatory cytokines (34, 35) and insulin (36–38) path-
ways. In agreement with this, HF-fed 11HSD1/ mice are
insulin-sensitized and have reduced adipose inflammation (12,
13).
We propose that increased local glucocorticoid amplifica-
tion exacerbates the metabolic insult caused by hypoxia and
consequent fibrosis in adipose tissue. The detrimental impact
on adipose tissue architecture may then lead to further meta-
bolic compromise of adipocytes. Thus, selective 11HSD1 inhi-
bitionmight prove to be beneficial both by increasing adipocyte
insulin sensitivity and function and by favoring enhanced
angiogenesis signals, allowing escape from adipose hypoxia and
fibrosis in obesity.
Acknowledgments—We acknowledge the support of the British Heart
Foundation Centre of Research Excellence. We are grateful to the
Centre for Inflammation Research Histology staff for excellent techni-
cal support and SheilaMacpherson in theMRC-Centre for Reproduc-
tive Biology (CRB) for expertise and generous help on CD31
immunohistochemistry.
REFERENCES
1. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K.,
Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., and Shimomura, I.
(2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine
dysregulation. Diabetes 56, 901–911
2. Rausch, M. E. Weisberg, S., Vardhana, P., and Tortoriello, D. V. (2008)
Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and
cytotoxic T-cell infiltration. Int. J. Obes. (Lon.) 32, 451–463
3. Yin, J., Gao, Z., He, Q., Zhou, D., Guo, Z., and Ye, J. (2009) Role of hypoxia
in obesity-induced disorders of glucose and lipid metabolism in adipose
tissue. Am. J. Physiol. Endocrinol. Metab. 296, E333–E342
4. Pasarica, M., Sereda, O. R., Redman, L. M., Albarado, D. C., Hymel, D. T.,
Roan, L. E., Rood, J. C., Burk, D. H., and Smith, S. R. (2009) Reduced
adipose tissue oxygenation in human obesity: evidence for rarefaction,
macrophage chemotaxis, and inflammation without an angiogenic re-
sponse. Diabetes 58, 718–725
5. Yun, Z., Maecker, H. L., Johnson, R. S., and Giaccia, A. J. (2002) Inhibition
of PPAR2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a
mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2,
331–341
6. Shimba, S., Wada, T., Hara, S., Tezuka, M. (2004) EPAS1 promotes adi-
pose differentiation in 3T3-L1 cells. J. Biol. Chem. 279, 40946–40953
7. Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie,
A. D., Sherwani, S., Wang, Z. V., Landskroner-Eiger, S., Dineen, S., Maga-
lang, U. J., Brekken, R. A., and Scherer, P. E. (2009) Hypoxia-inducible
factor 1 induces fibrosis and insulin resistance in white adipose tissue.
Molecular and cellular biology 29, 4467–4483
8. Rask, E., Olsson, T., Söderberg, S., Andrew, R., Livingstone, D. E., Johnson,
O., Walker, B. R. (2001) Tissue-specific dysregulation of cortisol metabo-
lism in human obesity. J. Clin. Endocrinol. Metab. 86, 1418–1421
9. Michailidou, Z., Jensen,M.D., Dumesic, D. A., Chapman, K. E., Seckl, J. R.,
Walker, B. R., and Morton, N. M (2007) Omental 11-hydroxysteroid
dehydrogenase 1 correlates with fat cell size independently of obesity.
Obesity 15, 1155–1163
10. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J.,
Seckl, J. R., and Flier, J. S. (2001) A transgenicmodel of visceral obesity and
the metabolic syndrome. Science 294, 2166–2170
11. Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D.,
Jamieson, P., Best, R., Brown, R., Edwards, C. R., Seckl, J. R., and Mullins,
J. J. (1997) 11-hydroxysteroid dehydrogenase type 1 knockoutmice show
attenuated glucocorticoid-inducible responses and resist hyperglycemia
on obesity or stress. Proc. Natl. Acad. Sci. U.S.A. 94, 14924–14929
12. Morton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B.,
Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., and Seckl, J. R. (2004)
Novel adipose tissue-mediated resistance to diet-induced visceral obesity
in 11-hydroxysteroid dehydrogenase type 1-deficient mice.Diabetes 53,
931–938
13. Wamil, M., Battle, J. H., Turban, S., Kipari, T., Seguret, D., de Sousa Pei-
xoto, R., Nelson, Y. B., Nowakowska, D., Ferenbach, D., Ramage, L., Chap-
man, K. E., Hughes, J., Dunbar, D. R., Seckl, J. R., Morton, N. M. (2011)
Novel fat depot-specific mechanisms underlie resistance to visceral obe-
sity and inflammation in 11-hydroxysteroid dehydrogenase type 1-defi-
cient mice. Diabetes 60, 1158–1167
14. Small, G. R., Hadoke, P. W., Sharif, I., Dover, A. R., Armour, D., Kenyon,
C. J., Gray, G. A., Walker, B. R. (2005) Preventing local regeneration of
glucocorticoids by 11-hydroxysteroid dehydrogenase type 1 enhances
angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 102, 12165–12170
15. McSweeney, S. J., Hadoke, P. W., Kozak, A. M, Small, G. R., Khaled, H.,
Walker, B. R., Gray, G. A. (2010) Improved heart function follows en-
hanced inflammatory cell recruitment and angiogenesis in 11HSD1-de-
ficient mice post-MI. Cardiovasc Res. 88, 159–167
16. Maxwell, P. H., Wiesener, M. S., Chang, G.W., Clifford, S. C., Vaux, E. C.,
Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe,
P. J. (1999) The tumor suppressor protein VHL targets hypoxia-inducible
factors for oxygen-dependent proteolysis. Nature 399, 271–275
17. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O’Rourke, J.,
Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian,
Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J.,
Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. (2001)
Caenorhabditis elegans EGL-9 and mammalian homologs define a family
of dioxygenases that regulateHIF by prolyl hydroxylation.Cell 107, 43–54
18. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A.,
Asara, J. M., Lane, W. S., and Kaelin, W. G., Jr. (2001) HIF targeted for
VHL-mediated destruction by proline hydroxylation: implications for O2
sensing. Science 292, 464–468
19. Copple, B. L., Bai, S., Moon, J. O. (2010) Hypoxia-inducible factor-depen-
dent production of profibrotic mediators by hypoxic Kupffer cells. Hepa-
tol. Res. 40, 530–539
20. Iredale, J. P. (2007) Models of liver fibrosis: exploring the dynamic nature
of inflammation and repair in a solid organ. J. Clin. invest. 117, 539–548
21. Eickelberg, O. (2001) Endless healing: TGF-, SMADs, and fibrosis. FEBS
Lett. 506, 11–14
22. Keophiphath, M., Achard, V., Henegar, C., Rouault, C., Clément, K., and
Lacasa, D. (2009) Macrophage-secreted factors promote a profibrotic
Reduced Adipose Fibrosis in 11HSD1Deficiency
4196 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 6•FEBRUARY 3, 2012
 by guest on June 19, 2013http://www.jbc.org/Downloaded from 
phenotype in human preadipocytes.Mol. Endocrinol. 23, 11–24
23. Friedman, S. L. (2010) Evolving challenges in hepatic fibrosis. Nat. Rev.
Gastroenterol. Hepatol. 7, 425–436
24. Stockmann, C., Kerdiles, Y., Nomaksteinsky,M.,Weidemann, A., Takeda,
N., Doedens, A., Torres-Collado, A. X., Iruela-Arispe, L., Nizet, V., and
Johnson, R. S. (2010) Loss of myeloid cell-derived vascular endothelial
growth factor accelerates fibrosis. Proc. Natl. Acad. Sci. U.S.A. 107,
4329–4334
25. Gealekman,O., Burkart, A., Chouinard,M., Nicoloro, S.M., Straubhaar, J.,
and Corvera, S. (2008) Enhanced angiogenesis in obesity and in response
to PPAR activators through adipocyteVEGF andANGPTL4 production.
Am. J. Physiol. Endocrinol. Metab. 295, E1056–E1064
26. Arany, Z., Foo, S. Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G.,
Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., Baek, K. H.,
Rosenzweig, A., and Spiegelman, B. M. (2008) HIF-independent regula-
tion of VEGF and angiogenesis by the transcriptional coactivator PGC-1.
Nature 451, 1008–1012
27. Ndubuizu, O. I., Tsipis, C. P., Li, A., LaManna, J. C. (2010) Hypoxia-
inducible factor-1 (HIF-1)-independent microvascular angiogenesis in
the aged rat brain. Brain Res. 1366, 101–109
28. Nauck, M., Karakiulakis, G., Perruchoud, A. P., Papakonstantinou, E.,
Roth, M. (1998) Corticosteroids inhibit the expression of the vascular
endothelial growth factor gene in human vascular smooth muscle cells.
Eur. J. Pharmacol. 341, 309–315
29. Leonard,M.O., Godson, C., Brady, H. R., Taylor, C. T. (2005) Potentiation
of glucocorticoid activity in hypoxia through induction of the glucocorti-
coid receptor. J. Immunol. 174, 2250–2257
30. De Sousa Peixoto, R. A., Turban, S., Battle, J. H., Chapman, K. E., Seckl,
J. R., Morton, N. M. (2008) Preadipocyte 11-hydroxysteroid dehydro-
genase type 1 is a keto-reductase and contributes to diet-induced visceral
obesity in vivo. Endocrinology 149, 1861–1868
31. Villaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M. A., Senge-
nès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., Bou-
loumié, A. (2010) Adipose tissue endothelial cells from obese human sub-
jects: differences among depots in angiogenic, metabolic, and
inflammatory gene expression and cellular senescence. Diabetes 59,
2755–2763
32. Ye, J., Gao, Z., Yin, J., and He, Q. (2007) Hypoxia is a potential risk factor
for chronic inflammation and adiponectin reduction in adipose tissue of
ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293,
E1118–E1128
33. Kodama, T., Shimizu, N., Yoshikawa, N., Makino, Y., Ouchida, R., Oka-
moto, K., Hisada, T., Nakamura, H., Morimoto, C., and Tanaka, H. (2003)
Role of the glucocorticoid receptor for regulation of hypoxia-dependent
gene expression. J. Biol. Chem. 278, 33384–33391
34. Haddad, J. J., Land, S. C. (2001) A non-hypoxic, ROS-sensitive pathway
mediates TNF--dependent regulation of HIF-1. FEBS Lett. 505,
269–274
35. Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J., Neckers, L. (2003) IL-1-mediated
up-regulation of HIF-1 via an NFB/COX-2 pathway identifies HIF-1 as
a critical link between inflammation and oncogenesis. FASEB J. 17,
2115–2117
36. Feldser, D., Agani, F., Iyer, N. V., Pak, B., Ferreira, G., and Semenza, G. L
(1999) Reciprocal positive regulation of hypoxia-inducible factor 1 and
insulin-like growth factor 2. Cancer Res. 59, 3915–3918
37. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., Van Obber-
ghen, E. (2002) Insulin stimulates hypoxia-inducible factor 1 through a
phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling
pathway. J. Biol. Chem. 277, 27975–27981
38. He, Q., Gao, Z., Yin, J., Zhang, J., Yun, Z., Ye, J. (2011) Regulation of
HIF-1 activity in adipose tissue by obesity-associated factors: adipogen-
esis, insulin, and hypoxia. Am. J. Physiol. Endocrinol. Metab. 300,
E877–885
Reduced Adipose Fibrosis in 11HSD1Deficiency
FEBRUARY 3, 2012•VOLUME 287•NUMBER 6 JOURNAL OF BIOLOGICAL CHEMISTRY 4197
 by guest on June 19, 2013http://www.jbc.org/Downloaded from 
Citations
 http://www.jbc.org/content/287/6/4188#otherarticles
This article has been cited by 3 HighWire-hosted articles: 
 by guest on June 19, 2013http://www.jbc.org/Downloaded from 
